LivaNova PLC (LIVN) Annals of Internal Medicine Publishes 12-Month Results from LivaNova’s OSPREY Clinical Study for Obstructive Sleep Apnea

LivaNova PLC (NASDAQ: LIVN) FY 2026 Other Release

Newsdesk: